MedTrace Logo

Gingival Bleeding and Von Willebrand Disease Typ 2 and 3

NCT03078595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2020-02-27

Study results available
· View outcomes & findings →

Summary

Von Willebrand disease (VWD) is the most common inherent bleeding disorder resulting in prolonged bleeding time. Gingival bleeding is a frequently reported symptom of VWD. However, gingival bleeding is also known as a leading symptom of plaque-induced gingivitis and untreated periodontal disease. Gingival bleeding in VWD patients may be triggered by gingival inflammation and not a genuine symptom. Thus, this study evaluates whether type 2 and 3 VWD determines an increased susceptibility to gingival bleeding in response to the oral biofilm.

Conditions

  • Gingival Bleeding
  • Von Willebrand Diseases

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Principal Investigators

  • Peter Eickholz, Prof. · Dept. of Perio, Center for Dent. and Oral Med., JWG-University Frankfurt

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-16
Primary Completion
2017-04-04
Completion
2017-04-04

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078595 on ClinicalTrials.gov